Analysis of pancreatic islets with CGRP-specific monoclonal antibodies in mouse models of diabetes and diet-induced obesity showed that CGRP blocked glucose-stimulated insulin secretion and reduced the expression of the insulin-2 gene. The gene discussed is INS; the disease is diabetes mellitus.